North Texas Inpatient & Geriatric Associates Pa is categorized under Doctors in Dallas, TX and active since 2003.
North Texas Inpatient & Geriatric Associates Pa was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Wafer Gamil at the company’s single location by writing to 9229 Lbj Freeway # 250, Dallas, Texas TX 75243 or by phoning (972) 739-3001. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | North Texas Inpatient & Geriatric Associates Pa |
Contact Person: | Wafer Gamil |
Address: | 9229 Lbj Freeway # 250, Dallas, Texas 75243 |
Phone Number: | (972) 739-3001 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2003 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
North Texas Inpatient & Geriatric Associates Pa was started in 2003 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Wafer Gamil for inquiries that concern North Texas Inpatient & Geriatric Associates Pa by calling the company number (972) 739-3001, as your correspondence is most welcome. Additionally, the physical location of the single location of North Texas Inpatient & Geriatric Associates Pa can be found at the coordinates 32.916363,-96.741536 as well as the street address 9229 Lbj Freeway # 250 in Dallas, Texas 75243.
For its online presence, you may visit North Texas Inpatient & Geriatric Associates Pa’s website at and engage with its social media outlets through on Twitter and on Facebook.